Tenuta, M.; Gelibter, A.; Pandozzi, C.; Sirgiovanni, G.; Campolo, F.; Venneri, M.A.; Caponnetto, S.; Cortesi, E.; Marchetti, P.; Isidori, A.M.;
et al. Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study. Cancers 2021, 13, 6355.
https://doi.org/10.3390/cancers13246355
AMA Style
Tenuta M, Gelibter A, Pandozzi C, Sirgiovanni G, Campolo F, Venneri MA, Caponnetto S, Cortesi E, Marchetti P, Isidori AM,
et al. Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study. Cancers. 2021; 13(24):6355.
https://doi.org/10.3390/cancers13246355
Chicago/Turabian Style
Tenuta, Marta, Alain Gelibter, Carla Pandozzi, Grazia Sirgiovanni, Federica Campolo, Mary Anna Venneri, Salvatore Caponnetto, Enrico Cortesi, Paolo Marchetti, Andrea M. Isidori,
and et al. 2021. "Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study" Cancers 13, no. 24: 6355.
https://doi.org/10.3390/cancers13246355
APA Style
Tenuta, M., Gelibter, A., Pandozzi, C., Sirgiovanni, G., Campolo, F., Venneri, M. A., Caponnetto, S., Cortesi, E., Marchetti, P., Isidori, A. M., & Sbardella, E.
(2021). Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study. Cancers, 13(24), 6355.
https://doi.org/10.3390/cancers13246355